VivoSim Labs, Inc. (VIVS) Operating Margin
- Operating margin · 12 months: Value -10116.96%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -10116.96% | Operating income / revenue. Period ending 2026-06-30. $-11.33M ÷ $112.00K × 100 ≈ -10116.96% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -11.33M USD | Operating Income (Loss) |
| Revenue | 112.00K USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | 4.32M USD | Research and Development Expense |
| Selling, general and administration | 7.12M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-11.33M | $112.00K | (m) | $4.32M | $7.12M | -10116.96% |
| 2026-03-31 | $-11.49M | $131.00K | $0.00 | $4.19M | $7.43M | -8768.70% |
| 2025-12-31 | $-11.45M | $142.00K | $0.00 | $3.92M | $7.67M | -8066.20% |
| 2025-09-30 | $-12.17M | $140.00K | $2.00K | $4.56M | $7.75M | -8694.29% |
| 2025-06-30 | $-12.14M | $142.00K | $3.00K | $4.62M | $7.66M | -8552.82% |
| 2025-03-31 | $-12.62M | $144.00K | $5.00K | $5.03M | $7.73M | -8761.11% |
| 2024-12-31 | $-12.56M | $122.00K | (m) | $5.23M | $7.45M | -10293.44% |
| 2024-09-30 | $-12.77M | $103.00K | (m) | $4.88M | $7.99M | -12398.06% |
| 2024-06-30 | $-14.28M | $73.00K | (m) | $5.23M | $9.11M | -19557.53% |
| 2024-03-31 | $-15.09M | $109.00K | (m) | $5.50M | $9.70M | -13840.37% |
| 2023-12-31 | $-19.77M | $242.00K | (m) | $9.88M | $10.13M | -8169.01% |
| 2023-09-30 | $-19.45M | $368.00K | (m) | $9.63M | $10.18M | -5284.78% |
| 2023-06-30 | $-18.69M | $445.00K | (m) | $9.53M | $9.60M | -4199.33% |
| 2023-03-31 | $-17.73M | $370.00K | (m) | $8.88M | $9.22M | -4792.16% |
| 2022-12-31 | $-11.87M | $1.71M | (m) | $4.57M | $9.00M | -694.67% |
| 2022-09-30 | $-12.01M | $1.58M | (m) | $4.31M | $9.27M | -761.32% |
| 2022-06-30 | $-12.16M | (m) | (m) | $3.76M | $9.90M | (m) |
| 2022-03-31 | $-11.48M | $1.50M | (m) | $3.32M | $9.66M | -765.27% |
| 2022-02-22 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $-12.16M | (m) | (m) | $2.86M | $9.31M | (m) |
| 2021-09-30 | $-11.16M | (m) | (m) | $2.33M | $8.82M | (m) |
| 2021-06-30 | $-16.60M | (m) | (m) | $1.68M | $14.92M | (m) |
| 2021-03-31 | $-16.83M | $0.00 | $0.00 | $1.10M | $15.72M | (m) |
| 2020-12-31 | $-17.12M | $0.00 | $0.00 | $301.00K | $16.82M | (m) |
| 2020-09-30 | $-19.86M | $298.00K | $13.00K | $44.00K | $20.10M | -6665.44% |
| 2020-06-30 | $-17.74M | $1.53M | $277.00K | $1.46M | $17.53M | -1160.99% |
| 2020-03-31 | $-21.48M | $2.20M | $328.00K | $5.28M | $18.06M | -977.91% |
| 2019-12-31 | $-25.74M | $2.88M | $429.00K | $9.82M | $18.37M | -895.13% |
| 2019-09-30 | $-27.04M | $3.36M | $552.00K | $13.45M | $16.39M | -805.36% |
| 2019-06-30 | $-26.22M | $3.07M | $413.00K | $15.20M | $13.68M | -854.01% |
| 2019-03-31 | $-27.27M | $3.09M | $482.00K | $14.75M | $15.13M | -882.37% |
| 2018-12-31 | $-27.70M | (m) | (m) | $14.32M | $16.23M | (m) |
| 2018-09-30 | $-29.08M | (m) | (m) | $14.54M | $17.70M | (m) |
| 2018-06-30 | $-32.65M | (m) | (m) | $16.30M | $19.80M | (m) |
| 2018-03-31 | $-35.27M | (m) | (m) | $17.96M | $20.89M | (m) |
| 2017-12-31 | $-38.38M | (m) | (m) | $19.52M | $22.24M | (m) |
| 2017-09-30 | $-40.10M | (m) | (m) | $20.54M | $22.92M | (m) |
| 2017-06-30 | $-40.00M | (m) | (m) | $20.13M | $23.10M | (m) |
| 2017-03-31 | $-38.58M | (m) | (m) | $19.55M | $22.30M | (m) |
| 2016-12-31 | $-36.32M | (m) | (m) | $18.55M | $20.96M | (m) |
| 2016-09-30 | $-37.16M | (m) | (m) | $18.11M | $21.62M | (m) |
| 2016-06-30 | $-38.96M | (m) | (m) | $18.31M | $22.55M | (m) |
| 2016-03-31 | $-38.64M | (m) | (m) | $18.01M | $22.12M | (m) |
| 2015-12-31 | $-38.18M | (m) | (m) | $17.11M | $22.28M | (m) |
| 2015-09-30 | $-34.67M | (m) | (m) | $15.76M | $19.94M | (m) |
| 2015-06-30 | $-32.34M | (m) | (m) | $14.25M | $18.87M | (m) |
| 2015-03-31 | $-30.30M | (m) | (m) | $12.92M | $17.95M | (m) |
| 2014-12-31 | $-29.01M | (m) | (m) | $11.77M | $17.66M | (m) |
| 2014-09-30 | $-26.68M | $399.00K | (m) | $10.91M | $16.16M | -6686.47% |
| 2014-06-30 | $-23.32M | $372.00K | (m) | $9.31M | $14.39M | -6270.16% |
| 2014-03-31 | $-20.65M | $379.00K | (m) | $7.97M | $13.05M | -5448.28% |
| 2013-12-31 | $-17.99M | $479.00K | (m) | $6.87M | $11.60M | -3755.11% |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | $-12.02M | $1.29M | (m) | $4.34M | $8.97M | -929.95% |
| 2012-12-31 | $-9.32M | $1.20M | (m) | $3.44M | $7.08M | -778.53% |
| 2012-09-30 | (m) | $848.21K | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | $380.65K | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | $374.16K | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |